Blood test could tell immunotherapy hepatitis apart from other liver inflammation
NCT ID NCT06470997
First seen Nov 21, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This study aims to find specific blood markers that can tell the difference between hepatitis caused by immune checkpoint inhibitors (a type of cancer immunotherapy) and other forms of autoimmune hepatitis. Researchers will compare blood samples from 60 adults with immunotherapy-related hepatitis to those with idiopathic autoimmune hepatitis. The goal is to improve diagnosis and guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-MEDIATED HEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Montpellier
RECRUITINGMontpellier, France, 34295, France
Contact
Conditions
Explore the condition pages connected to this study.